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In Vitro Fertilization:

Are There Stlll Ethical Problems?
CAROL A. TAUER, Ph.D.*

ABSTRACf-The initial development of the technique of in vitro fertilization (IVF) was accompanied by
discussion of related ethical questions. Two significant ones were: Did the development of IVF justify the
wastage of human embryos which made it possible? Was it_ justifiable to attemp_t human embryo transfer
without laboratory studies to determine the safety of the techmque? Thousands ofbtrths as a result ofiVF have
largely made these two questions moot. But four others remain: Is IVF immoral because it accomplishes
procreation in a laboratory rather than through an act of marital ul!ion? Is it permissible to maximize th~ succ_ess
of IVF through practices which result in the intentional destruction of human embryos or fetuses? Is tt ethtcal
to conduct basic scientific research which utilizes laboratory-fertilized embryos? Given uneven and often very
low success rates for IVF, should public policy act to protect clients or to promote improved IVF practice?While
our society is deeply divided as to the resolution of these problems, it is beginning to engage in public debate,
particularly on the last two questions.

Introduction
While our nation is still polarized, morally and politically,
on the issue of abortion, scientific advances raise new
questions about the appropriate treatment of prenatal life. In
two areas of scientific research, the questions are particularly
pressing and are currently receiving wide attention. The first
area concerns a generally accepted treatment for infertility
problems, in vitro fertilization or IVF. Because this procedure
involves fertilization of oocytes by sperm outside the body of
a woman, it provides opportunities for studies in reproductive biology which are not otherwise possible. The second
area concerns the use of tissue from aborted fetuses for
research and transplantation. As this technique begins to offer
the prospect of cures for a variety of severe conditions and
diseases, the need for significant quantities of fetal tissue
could be anticipated.
While these scientific advances offer hope to people who
are suffering from infertility or disability, they remind us that
our society has not come close to resolving fundamental
questions about the status of prenatal human life. The
Supreme Court in Roe v. Wade (1973) ruled that abortion
must be permitted up to the time of fetal viability. This
decision was based solely on the pregnant woman's right to

privacy, a right found to be constitutionally protected, that
allows her to choose an abortion. The Court made no other
statement regarding appropriate treatment of the previable
embryo or fetus, and in fact it noted that this matter was
beyond its competence. Adding to the ambiguity of the
situation, many persons and groups in our society do not
accept the ruling of Roe v. Wade, and have devoted themselves to overturning its provisions.
Meanwhile, scientists whose work involves the study of
prenatal human life wait for funding and regulatory agencies
to resolve questions about the ethics of their research. The
decisions of these agencies determine whether scientists will
be able to carry out the research they believe is essential for
progress in biology and medicine. Similarly, individuals and
families who are suffering from infertility or disease wait for
improved therapies which could enable them to have
children or to resume normal, reasonably healthy lives. Our
society finds itself tom between two competing values: the
pursuit of scientific advances which could significantly
improve human life, and respect for deeply held convictions
as to the value and sacredness of the prenatal human.
In this review I will concentrate on the specific ethical
questions raised by in vitro fertilization, leaving the issues
related to the use of fetal tissue for further consideration. In
the discussion, I will focus particularly on questions about the
appropriate treatment of the human embryo and fetus.

The Development of In Vitro Fertilization
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On July 25, 1978, Louise Brown, the first baby ever
conceived in a laboratory, was born in Oldham, England. Her
birth was possible only because of many years of laboratory
research and numerous clinical attempts to achieve pregnancy with this technique. The physician and the biologist
involved with Louise's birth, Patrick Steptoe and Robert
Edwards, had themselves worked for over ten years to achieve
this goal. As of February 1979, they had attempted the
technique with 79 infertile women, of whom only four had
become pregnant and only two had given birth (1).
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During the development period of in vitro fertilization, the
literature was filled with discussions of the ethical questions
raised. In retrospect, two of these questions seem most
significant because, even though they have been resolved in
a practical sense, their underlying theoretical issues remain
with us. Both of these questions illustrate the tension referred
to earlier, and each can be phrased in terms of competing
values.
• Does the development of in vitro fertilization justify the
wastage of human embryos which made it possible?
• Was it justifiable to attempt clinical embryo transfer
without laboratory studies to determine whether IVF was
safe for the developing embryos?
Wastage of Embryos
Given the high rate of infertility among couple who wish
to have children, estimated at one in six couples in the United
States, the development of techniques to assist them is a
laudable endeavor. In the process of developing IVF techniques, however, numerous attempts to fertilize human
oocytes were made in laboratories throughout the world. The
fi~st successful human fertilization was demonstrated by
Pterre Soupart ofVanderbilt University in January 1973 (2)."
Once fertilization was achieved, embryo transfer to the
woman who had provided the oocyte(s) could be attempted.
Since at first there was essentially no hope of success, i.e., that
the embryos would implant and develop to term, an
extended series of experiments was conducted from which
the embryos involved could not benefit.
While the goal of relieving infertility was a good one,
numerous embryos were created and then expired to support
the research needed to develop the in vitro technique.
According to those who regard these embryos as human
beings, literally hundreds of humans gave their lives so
infertility treatment could be made available, or so future
embryos could be conceived, implanted, and brought to
term. Depending on one's view of the moral status of the early
embryo, one may hold that the price of success was too high.
Safety of JVF
The second question raised during the period of initial
research involved the safety of the in vitro technique. Many
scientists wanted evidence that the manipulation of the
gametes and embryos in in vitro fertilization did not cause
birth defects. These scientists advocated laboratory studies on
1VF zygotes and cleaving embryos, so that safety would be
assured before transfer to a woman was attempted. While
prudent, this course of action would clearly require the use
of human embryos for laboratory studies, again raising the
question of the ethics of such research.
Pierre Soupart in 1978 criticized his British colleagues for
omitting human safety studies and moving immediately to
embryo transfer. At that time, Soupart had a research proposal
under consideration at the National Institutes of Child Health
and Human Development (NICHD) in which he proposed to
"establish the genetic risk involved in the obtaining of human
preimplantation embryos, by tissue culture methods (2). His
proposal never received final approval and funding, probably
because of its ethically controversial nature. Meanwhile,
Steptoe and Edwards achieved their immediate goal, the birth
of Louise Brown, and scientists and clinicians throughout the
world turned to learning the method and imitating their
accomplishment.
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The Current Situation
As Louise Brown's birth was followed in rapid succession
by hundreds and now thousands ofbirths resulting from IVF,
the ethical concerns shifted. These births showed no
evidence of increased defect or abnormality resulting from
the in vitro process. Hence, the question of testing the safety
of IVF became moot. The issue of embryo wastage also
became less problematic. If an attempt were made to transfer
each fertilized egg to a woman, then whatever embryo loss
occurred could be accepted, since each embryo had a real
chance to develop its potential and come to term.
During the decade beginning in 1978, in vitro fertilization
was regarded with hope and optimism by most people, from
research scientists to the general public. The news media
provided extensive coverage of the first IVF baby in a city or
state, and infertile couples flocked to the IVF clinics, which
sprang up in most major medical centers. As early as
December 1978, a Gallup poll showed that 60 percent of the
public approved of IVF, while only 27 percent opposed it (3 ).
Public concern seemed to be focused mainly on unusual
applications or unexpected problems: the woman in South
Africa who gave birth to her daughter's "test-tube" triplets in
1987, and the two fertilized eggs which were left frozen and
orphaned in Melbourne when their parents, Mario and Elsa
Rios, were killed in 1983.
Ethical questions remain, however. Three of them have
nagged us during the entire past decade, while the fourth is
an issue that has only recently received publicity. The first
three questions are: (1) Is IVF immoral because it accomplishes procreation within a laboratory rather than through an
act of marital union? (2) Is it permissible to maximize the
success of IVF by using practices that result in the intentional
destruction of human embryos or fetuses? (3) Now that
human embryos are available in the laboratory setting, is it
ethical to conduct the basic scientific research which could
be undertaken? The fourth question, raised only recently, is
this: Given that the success rates for IVF are vastly uneven and
often unacceptably low, should public policy be implemented to protect clients or to promote improvements in the
technique?

Separating Procreation from Marital Union
In vitro fertilization achieves a good result, pregnancy and
childbirth for an otherwise infertile couple, through what
some conservative thinkers regard as an intrinsically bad
means. The foremost critic of IVF on grounds that it is
intrinsically wrong is probably the Roman Catholic Church.
In its instruction on procreation of February 1987, the Vatican
stated that artificial fertilization in the form of IVF is not
morally acceptable. The reason given is that IVF separates
procreation from the act of intercourse, which is the sign of
the spouses' union ( 4). Thus, it is illicit for the same reason
that artificial contraception is illicit.
This view is not uniformlly held among Catholic theologians, however. Note, for example, the position of Richard A
McCormick, SJ., who argues that procreation must take place
within the context of a loving marital relationship, but that it
need not be the fruit of a specific conjugal act (5). As Baruch
Brody points out in his fine study of religious perspectives on
IVF, a number of religious communities share McCormick's
view, while he knows of no others who support the official
position of the Roman Catholic Church (6).

journal of the Minnesota Academy of Science

Taking Chances to Improve One's Chances
A whole set of ethical issues arises from attempts to
optimize the outcome for the couple seeking a child through
IVF. Their chances of obtaining a child as the result of a single
attempt at fertilization and implantation are very small. Hence
various approaches have been devised for increasing the
odds. Some of these procedures raise ethical questions at the
same time as they further a laudable goal.
In order to maximize the probability of fertilization and
pregnancy, the woman is generally given hormonal treatment
to cause her to superovulate, or to produce more than one
egg in a given cycle. These eggs, usually recovered by
laparoscopy, may all become fertilized. If more than one are
then transferred to the woman, her chances of achieving a
pregnancy will increase proportionately. But the likelihood of
a multiple pregnancy will also increase as the number of
transferred embryos becomes larger. If three or more of the
transferred embryos implant and begin to develop, the
woman will be carrying a high risk pregnancy; triplet and
higher multiple pregnancies almost certainly will result in
premature birth, with consequent morbidity or mortality.
Ought one to maximize the probability of pregnancy by
risking such an outcome? Options that have been proposed
include the following:
( 1) Limit the number of embryos to be fertilized and
transferred to three. The probability that all three will implant
is very small.
(2) Transfer all fertilized eggs, and if an excessive number
implant, use a procedure called selective reduction. In this
procedure, a certain number of fetuses are killed, either by
a transvaginal technique which aspirates the fluid and fetus
from the sac, or transabdominally through injection of
potassium chloride into the fetal heart (7).
(3) Fertilize all oocytes recovered, but transfer only two or
three. The others may be frozen for future use, donated to
another woman, discarded, or used for research.
While the aim may be to increase the probability of an
eventual successful outcome, options (2) and (3) raise
questions about the ethical treatment of human embryos and
fetuses. Selective reduction may be a choice one is almost
forced to make after a highly dangerous pregnancy has
occurred. Yet the initial decision to risk causing this type of
prenancy was a deliberate one. One cannot shirk responsibility for the consequences of deliberate decisions.
Freezing excess fertilized embryos has generally been
regarded as ethically more acceptable than destroying them.
However, from one-quarter to one-half of these embryos do
not survive the process of freezing and thawing, even in the
well-established clinics; and in the absence of better
diagnostic techniques, thawed embryos are transferred on the
basis of whether they "look good" or "look odd." In a recent
article, Andrea Bonnicksen delineates additional ethical
problems related to the freezing of embryos, ranging from
their legal status to how they are either personalized or
depersonalized by the donors or physicians, depending on
what they believe the eventual use and outcome will be (8).
Freezing, which once seemed like a simple solution to the
problem of excess embryos, has now provided a host of new
problems.
The University of Minnesota established its program for in
vitro fertilization in early 1983. Initially, all eggs which
fertilized were transferred back to the woman, with the
exception that "obviously abnormal embryonic cells will be
discarded and not used for fertilization (9)." Recently
freezing has become an option, and in 1988, a pregnancy was
Volume 54, Number 3, 1989

achieved using a frozen embryo. Dr. George Tagatz, director
of the program, reports that they are currently implanting up
to four embryos at a time, and that he is aware that a selective
reduction has occurred in the course of a triplet pregnancy
( 10 ). Within this program, Dr. Tagatz presents the possible
options to the couple seeking IVF, explains their risks and
benefits, and then allows the couple to choose the option
they prefer. He suggests that he is taking a less paternalistic
approach than he did at the beginning of the program, a
stance in line with a general trend in physician-patient
relationships. This approach has much to commend it. When
the fate of human embryos and fetuses is involved, however,
one may ask whether paternalism toward them would be an
appropriate ethical response, which may supersede the
exercise of parental autonomy.
Using Early Embryos in Research
A debate which continues to plague the scientific, ethical,
and political scene echoes earlier discussions of research
involving human embryos that cannot benefit from it. The
presence of human zygotes and embryos in the laboratory
setting provides scientists with an unusual opportunity to
investigate aspects of human reproduction. The process of
cell differentiation, the nature of genetic diseases, reasons for
miscarriage, new contraceptive methods, as well as investigations of other phenomena such as cancer-causing cells:
scientists have envisioned a wide variety of valuable research
utilizing laboratory-fertilized embryos (11). Eventually, too,
a kind of prenatal therapy might be developed; genetic
manipulation through gene "surgery" or replacement could
possibly be performed on the undifferentiated embryo.
In the United States, research involving fetuses is governed
by federal regulations, which were implemented in 1975.
However, these regulations do not cover research involving
preimplantation embryos; such research must be approved
by an Ethics Advisory Board or EAB (12). The EAB was
appointed in 1977, and after careful study, it issued general
guidelines to govern federally-funded research involving in
vitro fertilization. Research could ethically be conducted in
order to demonstrate the safety and efficacy of in vitro
fertilization, provided the gamete donors gave consent, and
on condition that the embryos were not sustained in the
laboratory beyond 14 days. The board did not approve or
disapprove other possible goals of embryo research, but did
take a big step in accepting the use of some embryos for
purposes beyond the development of their own potential.
While this report might have formed the basis for consideration of a series of research proposals, the EAB only
reviewed one proposal (Pierre Soupart's) during its brief
lifetime. Its report was tabled by HEW, its charter expired in
1980, and no human IVF research has been considered for
federal funding since that time.
Whether embryo research should or should not be
facilitated by public policy is highly debatable, but it is an
issue worth debating. Because of the demise of the Ethics
Advisory Board which was mandated to make recommendations in this area, and because of the generally volatile
atmosphere in the U.S. on abortion-related issues, there has
been a conspicuous absence of American public debate on
in vitro research during the past decade. In contrast, in
Australia, Great Britain, and other countries of the European
community, there has been vigorous public discussion for a
number of years. In Great Britain, the debate has even
reached parliamentary level. Recently an international
conference convened in Canada to develop "An International
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Ethic for Research with Human Beings (13)." Among other
issues, this conference began to explore the ethics of
laboratory research with human embryos at the international
level.
It is well-known that many persons and a number of
religious groups hold that the moment of fertilization marks
the beginning of a new human life, and that the zygote and
early embryo must be given all the protections due to a
human being. What is not as well known is the fact that some
conservative ethicists and theologians, even within bodies
like the Roman Catholic Church, have come to regard the
period immediately following fertilization (variously estimated from 7 to 14 days post-fertilization) as somewhat
anomalous (14, 15, 16, 17, 18). During this time, the dividing
embryonic cells behave more as a cellular mass than as a
unified organism. The cells are totipotential, each one having
the ability to develop into any sort of organ or tissue, or in
fact, into an entire fetus. If some of the cells are destroyed or
damaged, the others can go on to develop normally. Twinning or embryonic cloning, and conversely, the recombining
of two or more embryos, are possible during this period.
Thus, it might be said that we do not have an individual and
integrated human organism until differentiation has begun
and the phenomena of twinning and recombination are no
longer possible-a time that is generally identified as 14 days
after fertilization.
The unusual character and status of the very early embryo,
often called the preembryo, have led various advisory bodies
to permit research on preembryos up to 14 days gestational
age, but not thereafter. Persons who recognize full human
status at fertilization could not support such a position; but
a broad spectrum of informed ethical opinion seems willing
to permit it. In fact, the only public policy body in the U.S.
which considered the matter, the Ethics Advisory Board of
1977-78, approved the funding of certain types of embryo
research if limited to this 14-day period.
Providing IVF as Effective Therapy
Recently an additional ethical issue related to in vitro
fertilization has been given prominent attention. Critics noted
that, after a decade of clinical application of IVF, the success
rates for the procedure were still low, and in many clinics,
unacceptably low. On the one hand, there was fear that the
public, and more importantly, infertile couples, were being
misled by distorted claims for the success ofiVF. On the other
hand, there was concern that the efficacy of the procedure
could not be improved unless IVF research was encouraged
and funded.
Currently, it is difficult to obtain accurate and reliable
statistical data on the success rate for IVF. Clinics are not
required to report to any registry or regulatory body.
Published statistics usually represent a group of clinics, so that
figures from an individual center cannot be distinguished. In
addition, a "success" may be counted in a variety of ways:
fertilization and transfer, a biochemical pregnancy (rising {3hCG level), a clinical pregnancy (sac with discernible fetus
and positive heartbeat), or an actually delivered infant
(premature or full-term). Since the rate of spontaneous
abortions among IVF clinical pregnancies is high, about 50
percent (10), counting clinical pregnancies as successes will
obviously skew the data. An infertile couple wants a baby, not
just a pregnancy.
Individual clinics differ greatly in the information they
provide to prospective clients, often misleading them
(whether intentionally or not) as to their actual chances of
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success (19). In providing data to central registries, however,
most clinics now report the success rate as the number of live
births compared with the number of oocyte retrieval cycles.
Arthur Caplan, Director of the University of Minnesota Center
for Biomedical Ethics, cites two reports on the efficacy of IVF
that use this method of calculating (20). The first report,
combining 30 centers in the United Kingdom in 1985, shows
a success rate of 8.9 percent. The second, grouping data
voluntarily reported from 41 American clinics in 1986, shows
a rate of 6.4 percent. While these percentages are low, the
least efficient centers may not even be included in the
published data. A survey by the American Fertility Society
indicates that about half of the clinics that offer in vitro
fertilization in the United States have not yet produced a baby.
Experts estimate that about half of the 3000 births resulting
from IVF in the United States have occurred at just three
centers (19). While the University of Minnesota program is
smaller than these three, its success rates are relatively high.
Out of 56 oocyte retrievals in an 18-month period from July
1985 through 1986, 14 percent resulted in live births. Out of
52 retrievals in 1987, 17 percent produced babies (10).
Because of the desperate need experienced by many
infertile couples, they are easy targets for exploitation.
Infertility treatments carry a heavy emotional and psychological cost; couples describe themselves as being on an
emotional roller coaster. The financial cost is also high,
generally between $4500 and $6500 for each attempt, besides
expenses for travel, relocation, and lost work time. A
subcommittee of the House Committee on Small Business
has recently conducted hearings to determine whether the
IVF "business" is taking unfair advantage of the plight of these
couples. Currently, this subcommittee is conducting a survey
of the 169 U.S. clinics that offer IVF; the survey will help the
subcommittee decide whether federal regulation and/or a
national registry should be instituted.
The medical profession ordinarily regulates itself, but the
potential for abuse in the uncharted territory of new
reproductive techniques may call for supplementary measures. Two simple requirements would address many of the
problems that have been noted. The first step is to require
each clinic to provide unambiguous, easily understandable
data about its record of past successes, using a standard
method of calculating. Besides sharing this information with
clients, the clinic should be required to report it to a national
registry, so that a database for assessment and planning can
be developed. The second step is to set minimum requirements for practice in this field, leading to licensure of centers
that qualify. A center that did not meet the licensure standards
would not be eligible for payment by private insurers or
public funds. (Five states currently require insurance
companies to cover infertility treatment: Arkansas, Hawaii,
Maryland, Massachusetts, and Texas.)
These two measures, which Congress has begun to
consider, are straightforward means of handling alreadyidentified problems. They are relatively uncontroversial,
since their aim is to prevent exploitation, deceptive practices,
and the exercise of professional incompetence. Thus they
operate within the framework of consumer protection, a
legitimate function of government.
A third possible step is more controversial. In assessing the
statistical data available, Arthur Caplan comments that the
overall rate of success, well below one in ten, appears very
low for a medical procedure that is described as a therapy.
Ordinarily, one expects a better chance of success from a
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therapeutic procedure. How can this rate actually be
improved, not just in the best centers, but for a broad range
of competent ones?
At present, scientific and technical aspects of IVF are
explored largely through a trial and error process. Many
factors can be varied, from the dosage levels of the hormones
which produce superovulation, to the environmental
circumstances surrounding the transfer of embryos. Clinicians and scientists may discover empirically that one
approach works better than another, but they know little
about wiry it does. Because there has been essentially no basic
research on IVF in the United States since 1975, clinical
advances are not supported by advances in the scientific
knowledge base. As Caplan notes, "More than 160 IVF centers
exist but almost no American scientists are trying to understand how IVF works (20)."
Thus, we are again confronted with the question of
whether research on in vitro fertilization, which necessarily
involves research with early human embryos, is morally
permissible. In response to growing concern about this
matter, Dr. Otis Bowen, Secretary of Health and Human
Services, announced on]uly 14, 1988 that the first steps were
being taken toward formation of a new Ethics Advisory Board.
The charter for this board was published in the Federal
Register of September 12, 1988, and public comment has been
received. Whether the board will actually be chartered
depends on the apointments of the Bush administration to
Health and Human Services.
If the board is established, applications from scientists who
propose to do fertility research involving preembryos can
again be considered for federal funding. The board's
establishment would mark the beginning of a new era in the
history of IVF: the problems discussed in this review would
not then be solved, but they would be debated in the forum
of our public life and public policy.
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